COMTAN Side Effects

7021541-7 | Abasia, Impaired Driving Ability, Initial Insomnia, Movement Disorder, Muscle Spasms, Musculoskeletal Stiffness, Pain
on Jul 02, 2010 Female patient from UNITED STATES , 62 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Comtan (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, impaired driving ability, initial insomnia, movement disorder (What is movement disorder?), muscle spasms, musculoskeletal stiffness, pain (What is pain?). Comtan dosage: 200 Mg,. During the same period patient was treated with REQUIP XL (See Image) (View Requip Xl Review and Requip Xl Label ), CO CARELDOPA (200 MG) (LEVODOPA) (100/25 Mg, Oral; 800 Mg, 4 In 1 D, Oral) (View Co-careldopa (200 Mg) (levodopa) Review and Co-careldopa (200 Mg) (levodopa) Label ), CO CARELDOPA (200 MG) (LEVODOPA) (100/25 Mg, Oral; 800 Mg, 4 In 1 D, Oral) (View Co-careldopa (200 Mg) (levodopa) Review and Co-careldopa (200 Mg) (levodopa) Label ), APOKYN (03 Ml As Needed, Twice Or Four Times A Day Or Sometimes Not At All, Injection Nos) (View Apokyn Review and Apokyn Label ).

6991922-6 | Compulsions, Depression, Obsessive Thoughts, Obsessive-compulsive Disorder
Patient was taking Comtan (View Usage). Patient had the following side effects: compulsions, depression (What is depression?), obsessive thoughts, obsessive-compulsive disorder (What is obsessive-compulsive disorder?) on Sep 06, 2010 from FRANCE Additional patient health information: Female patient , 61 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?), depressive symptom and. Comtan dosage: 1200 Mg, Qd. During the same period patient was treated with MODOPAR (2000 Mg, Qd) (View Modopar Review and Modopar Label ), PRAMIPEXOLE DIHYDROCHLORIDE (3.5 Mg, Qd) (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ), AZILECT (1 Mg Per Os At 1 Tablet Daily) (View Azilect Review and Azilect Label ), ESCITALOPRAM (Once Per Day) (View Escitalopram Review and Escitalopram Label ). Patient was hospitalized.

6982083-8 | Hallucination, Visual
Adverse event was reported on Aug 25, 2010 by a Male patient taking Comtan (View Usage) (Dosage: 100 Mg Daily Oral,200 Mg, Oral) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: JAPAN , 75 years of age, After Comtan was administered, patient had the following side effects: hallucination, visual. During the same period patient was treated with LEVODOPA CARBIPOPA (View Levodopa-carbipopa Review and Levodopa-carbipopa Label ).

6982082-6 | Acute Pulmonary Oedema, Cardiac Failure, Colon Adenoma, Hiatus Hernia, Iron Deficiency Anaemia
on Aug 27, 2010 Male patient from FRANCE , 77 years of age, weighting 154.3 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Comtan (View Usage). Patient experienced the following unwanted or unexpected effects: acute pulmonary oedema, cardiac failure, colon adenoma, hiatus hernia, iron deficiency anaemia. Comtan dosage: 800 Mg Daily (4 Tablet Daily) Oral. During the same period patient was treated with SINEMET (View Sinemet Review and Sinemet Label ), EFFEXOR XR (View Effexor Xr Review and Effexor Xr Label ), XANAX (View Xanax Review and Xanax Label ), LOXEN (View Loxen Review and Loxen Label ). Patient was hospitalized.


6982081-4 | Loss Of Consciousness, Road Traffic Accident, Sudden Onset Of Sleep
on Sep 01, 2010 Female patient from JAPAN , 62 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Comtan (View Usage). Patient had the following side effects: loss of consciousness, road traffic accident, sudden onset of sleep. Comtan dosage: 100 Mg Daily Oral. During the same period patient was treated with BI SIFROL (PRAMIPEXOLE) (1.5 Mg Daily Oral) (View Bi-sifrol (pramipexole) Review and Bi-sifrol (pramipexole) Label ), CARBIDOPA AND LEVODOPA (300 Mg Daily Oral) (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ), ZOLOFT (2 Df, Daily) (View Zoloft Review and Zoloft Label ), MENESIT (View Menesit Review and Menesit Label ), ARTANE (View Artane Review and Artane Label ).

6977330-2 | Anaemia, Blood Iron Decreased
Patient was taking Comtan (View Usage). After Comtan was administered, patient had the following side effects: anaemia, blood iron decreased on Aug 23, 2010 from FRANCE Additional patient health information: Female patient , weighting 110.2 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Comtan dosage: 200 Mg, 6qd. During the same period patient was treated with SINEMET (100 Mg, 8qd) (View Sinemet Review and Sinemet Label ), PARLODEL (10 Mg, Tid) (View Parlodel Review and Parlodel Label ), MOTILIUM (View Motilium Review and Motilium Label ), MANTADIX (View Mantadix Review and Mantadix Label ).

6969964-6 | Confusional State, Hypersexuality, Paranoia
Adverse event was reported on Aug 31, 2010 by a Male patient taking Comtan (View Usage) (Dosage: 200 Mg,unk) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: UNITED STATES , 80 years of age, weighting 374.8 lb, Patient experienced the following unwanted or unexpected effects: confusional state, hypersexuality, paranoia. During the same period patient was treated with SINEMET (Unk,unk) (View Sinemet Review and Sinemet Label ).

6960133-2 | Loss Of Consciousness, Sudden Onset Of Sleep
on Aug 24, 2010 Female patient from JAPAN , 62 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Comtan (View Usage). Patient had the following side effects: loss of consciousness, sudden onset of sleep. Comtan dosage: 100 Mg, Qd. During the same period patient was treated with PRAMIPEXOLE DIHYDROCHLORIDE (1.5 Mg, Qd) (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ), CARBIDOPA AND LEVODOPA (300 Mg, Qd) (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ), ZOLOFT (2 Df, Qd) (View Zoloft Review and Zoloft Label ), MENESIT (300 Mg, Unk) (View Menesit Review and Menesit Label ), ARTANE (View Artane Review and Artane Label ).

6945077-4 | Acute Pulmonary Oedema, Asthenia, Cardiac Failure, Colon Adenoma, Colonic Polyp, Dysplasia, Dyspnoea, Hiatus Hernia, Iron Deficiency
on Aug 23, 2010 Male patient from FRANCE , weighting 154.3 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Comtan (View Usage). After Comtan was administered, patient had the following side effects: acute pulmonary oedema, asthenia, cardiac failure, colon adenoma, colonic polyp (What is colonic polyp?), dysplasia, dyspnoea, hiatus hernia, iron deficiency. Comtan dosage: 800 Mg Daily (4 Tablet Daily). During the same period patient was treated with SINEMET (250, (4 Df Daily)) (View Sinemet Review and Sinemet Label ), EFFEXOR XR (37.5, (1 Df Daily)) (View Effexor Xr Review and Effexor Xr Label ), XANAX (0.5, (1 Df Daily)) (View Xanax Review and Xanax Label ), LOXEN (Unk) (View Loxen Review and Loxen Label ). Patient was hospitalized.

6921510-9 | Athetosis, Chorea, Diaphragmatic Disorder, Headache, Weight Decreased
Patient was taking Comtan (View Usage). Patient experienced the following unwanted or unexpected effects: athetosis, chorea, diaphragmatic disorder, headache (What is headache?), weight decreased on Aug 09, 2010 from BRAZIL Additional patient health information: Female patient , 48 years of age, weighting 130.1 lb, was diagnosed with parkinson's disease (What is parkinson's disease?), headache (What is headache?) and. Comtan dosage: 1 Df, Tid. During the same period patient was treated with PROLOPA ((levodopa/benserazide): 4 Tablets Daily: 0.5 Tablet Every 3 Hours) (View Prolopa Review and Prolopa Label ), NEOSALDINA (40 Drops Daily) (View Neosaldina Review and Neosaldina Label ).

6916457-8 | Constipation, Dysarthria, Dyskinesia, Nausea, Paralysis, Weight Increased
Adverse event was reported on Jul 28, 2010 by a Female patient taking Comtan (View Usage) (Dosage: 200 Mg) was diagnosed with parkinson's disease (What is parkinson's disease?), depression (What is depression?) and. Location: BRAZIL , 72 years of age, Patient had the following side effects: constipation (What is constipation?), dysarthria, dyskinesia, nausea (What is nausea?), paralysis (What is paralysis?), weight increased. During the same period patient was treated with PAMELOR (Unk) (View Pamelor Review and Pamelor Label ), PROLOPA (1 Tablet, Every Three Hours) (View Prolopa Review and Prolopa Label ).

6914034-6 | Athetosis, Chorea, Diaphragmatic Disorder, Headache, Weight Decreased
on Jul 27, 2010 Female patient from BRAZIL , 48 years of age, weighting 130.1 lb, was diagnosed with parkinson's disease (What is parkinson's disease?), headache (What is headache?) and was treated with Comtan (View Usage). After Comtan was administered, patient had the following side effects: athetosis, chorea, diaphragmatic disorder, headache (What is headache?), weight decreased. Comtan dosage: 1 Df, Tid. During the same period patient was treated with PROLOPA ((levodopa/benserazide): 4 Tablets Daily: 0.5 Tablet Every 3 Hours) (View Prolopa Review and Prolopa Label ), NEOSALDINA (40 Drops Daily) (View Neosaldina Review and Neosaldina Label ).

6913522-6 | Activities Of Daily Living Impaired, Condition Aggravated, Dyskinesia, On And Off Phenomenon
on Jul 28, 2010 Female patient from JAPAN , 59 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Comtan (View Usage). Patient experienced the following unwanted or unexpected effects: activities of daily living impaired, condition aggravated, dyskinesia, on and off phenomenon. Comtan dosage: 250 Mg Daily Oral ; Increased To 300 Mg Daily Oral ; Decreased To 250 Mg Daily Oral. During the same period patient was treated with CARBIDOPA AND LEVODOPA (250 Mg/day Oral ; 5 Doses Per Day Oral) (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ), BI SIPROL (PRAMIPEXOLE) (3 Df Daily Oral ; Increased To 4 Df Daily Oral) (View Bi-siprol (pramipexole) Review and Bi-siprol (pramipexole) Label ), BI SIPROL (PRAMIPEXOLE) (3 Df Daily Oral ; Increased To 4 Df Daily Oral) (View Bi-siprol (pramipexole) Review and Bi-siprol (pramipexole) Label ), PRAMIVERINE HYDROCHLORIDE (View Pramiverine Hydrochloride Review and Pramiverine Hydrochloride Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ). Patient was hospitalized.

6895503-4 | Loss Of Consciousness
Patient was taking Comtan (View Usage). Patient had the following side effects: loss of consciousness on Jul 23, 2010 from JAPAN Additional patient health information: Female patient , 62 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Comtan dosage: 100 Mg, Qd. During the same period patient was treated with PRAMIPEXOLE DIHYDROCHLORIDE (1.5 Mg, Qd) (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ), MENESIT (300 Mg, Unk) (View Menesit Review and Menesit Label ).

6866391-7 | Activities Of Daily Living Impaired, Dyskinesia, On And Off Phenomenon, Parkinson's Disease
Adverse event was reported on Jul 15, 2010 by a Female patient taking Comtan (View Usage) (Dosage: Unk) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: JAPAN , 59 years of age, After Comtan was administered, patient had the following side effects: activities of daily living impaired, dyskinesia, on and off phenomenon, parkinson's disease (What is parkinson's disease?). During the same period patient was treated with CARBIDOPA AND LEVODOPA (250 Mg/day (5 Divided Doses)) (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ), PRAMIVERINE HYDROCHLORIDE (Unk) (View Pramiverine Hydrochloride Review and Pramiverine Hydrochloride Label ), PRAMIPEXOLE DIHYDROCHLORIDE (Unk) (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ), VITAMIN C (Unk) (View Vitamin C Review and Vitamin C Label ). Patient was hospitalized.

6836633-2 | Dyskinesia, On And Off Phenomenon
on Jul 07, 2010 Female patient from JAPAN , 59 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Comtan (View Usage). Patient experienced the following unwanted or unexpected effects: dyskinesia, on and off phenomenon. Comtan dosage: Unk. During the same period patient was treated with CARBIDOPA AND LEVODOPA (250 Mg, Unk) (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ), PRAMIVERINE HYDROCHLORIDE (Unk) (View Pramiverine Hydrochloride Review and Pramiverine Hydrochloride Label ). Patient was hospitalized.

6810338-6 | Anaemia, Polyp
on Jun 21, 2010 Male patient from FRANCE , 78 years of age, was treated with Comtan (View Usage). Patient had the following side effects: anaemia, polyp. Comtan dosage: Unk, Unk.

6800955-1 | Blood Albumin Decreased, Oedema Peripheral, Pleural Effusion, Protein Total Abnormal
Patient was taking Comtan (View Usage). After Comtan was administered, patient had the following side effects: blood albumin decreased, oedema peripheral, pleural effusion, protein total abnormal on Jun 22, 2010 from JAPAN Additional patient health information: Female patient , 77 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Comtan dosage: 600 Mg, Daily. During the same period patient was treated with CABASER (1 Mg, Unk) (View Cabaser Review and Cabaser Label ), MADOPAR (600 Mg, Unk) (View Madopar Review and Madopar Label ). Patient was hospitalized.

6800946-0 | Pleural Effusion
Adverse event was reported on Jun 22, 2010 by a Female patient taking Comtan (View Usage) (Dosage: 200 Mg, Daily) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: JAPAN , 77 years of age, Patient experienced the following unwanted or unexpected effects: pleural effusion. During the same period patient was treated with REQUIP (2 Mg, Unk) (View Requip Review and Requip Label ), MADOPAR (400 Mg, Unk) (View Madopar Review and Madopar Label ). Patient was hospitalized.

6767592-9 | Chest Pain, Depersonalisation, Derealisation, Pollakiuria, Somnolence
on Jun 08, 2010 Male patient from JAPAN , weighting 138.9 lb, was diagnosed with parkinson's disease (What is parkinson's disease?), hypoaesthesia, abdominal discomfort, depression (What is depression?) and was treated with Comtan (View Usage). Patient had the following side effects: chest pain (What is chest pain?), depersonalisation, derealisation, pollakiuria, somnolence. Comtan dosage: 400 Mg, Daily. During the same period patient was treated with CARBIDOPA AND LEVODOPA (450 Mg, Unk) (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ), PRAMIPEXOLE DIHYDROCHLORIDE (2 Mg, Unk) (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ), CYANOCOBALAMIN (1500 Ug, Unk) (View Cyanocobalamin Review and Cyanocobalamin Label ), GASTER (20 Mg, Unk) (View Gaster Review and Gaster Label ), TETRAMIDE (30 Mg, Unk) (View Tetramide Review and Tetramide Label ), RIVOTRIL (2 Mg, Unk) (View Rivotril Review and Rivotril Label ), SEDIEL (60mg, Unk) (View Sediel Review and Sediel Label ).

6760446-3 | Condition Aggravated, Gait Disturbance, Hepatic Function Abnormal, Malaise
on May 27, 2010 Male patient from JAPAN , weighting 147.7 lb, was diagnosed with parkinson's disease (What is parkinson's disease?), benign prostatic hyperplasia and was treated with Comtan (View Usage). After Comtan was administered, patient had the following side effects: condition aggravated, gait disturbance, hepatic function abnormal, malaise. Comtan dosage: 100 Mg, Qd. During the same period patient was treated with MODOPAR (150 Mg, Unk) (View Modopar Review and Modopar Label ), SELEGILINE HCL (2.5 Mg, Unk) (View Selegiline Hcl Review and Selegiline Hcl Label ), DOMIN (0.4 Mg, Unk) (View Domin Review and Domin Label ), PROSTAL (50 Mg, Unk) (View Prostal Review and Prostal Label ), HARNAL (0.1 Mg, Unk) (View Harnal Review and Harnal Label ). Patient was hospitalized.

6744554-9 | Incoherent
Patient was taking Comtan (View Usage). Patient experienced the following unwanted or unexpected effects: incoherent on May 17, 2010 from UNITED STATES Additional patient health information: Male patient , 70 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Comtan dosage: 200 Mg, Unk. During the same period patient was treated with TASMAR (Unk, Unk) (View Tasmar Review and Tasmar Label ). Patient was hospitalized.

6712179-7 | Abnormal Behaviour, Catatonia, Immobile, Muscle Rigidity, Mutism, Negativism, Waxy Flexibility
Adverse event was reported on Feb 24, 2010 by a Female patient taking Comtan (View Usage) (Dosage: 700 Mg, Daily) was diagnosed with mental disorder, parkinson's disease (What is parkinson's disease?) and. Location: FINLAND , 75 years of age, Patient had the following side effects: abnormal behaviour, catatonia, immobile, muscle rigidity, mutism, negativism, waxy flexibility. During the same period patient was treated with CARBIDOPA AND LEVODOPA (300 Mg, Daily) (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ).

6706519-2 | Fatigue, Pain, Tremor
on Apr 28, 2010 Male patient from BRAZIL , weighting 119.0 lb, was diagnosed with parkinson's disease (What is parkinson's disease?), blood cholesterol, blood pressure increased and was treated with Comtan (View Usage). After Comtan was administered, patient had the following side effects: fatigue, pain (What is pain?), tremor. Comtan dosage: 1 Tablet Five Times Daily: 6h00, 10h00, 14h00, 20h00 And 22h00. During the same period patient was treated with PROLOPA (1 Tablet Five Times Daily: 6h00, 10h00, 14h00, 20h00 And 22h00) (View Prolopa Review and Prolopa Label ), TRAZODONE HCL (Unk) (View Trazodone Hcl Review and Trazodone Hcl Label ), SIMVASTATIN (1 Tablet, Bid) (View Simvastatin Review and Simvastatin Label ), CAPTOPRIL (1 Tablet Bid: Morning And Night) (View Captopril Review and Captopril Label ).

6656545-7 | Hyponatraemia, Inappropriate Antidiuretic Hormone Secretion
on Mar 23, 2010 Male patient from JAPAN , 60 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Comtan (View Usage). Patient experienced the following unwanted or unexpected effects: hyponatraemia, inappropriate antidiuretic hormone secretion. Comtan dosage: 400 Mg. During the same period patient was treated with PRAMIPEXOLE DIHYDROCHLORIDE (3 Mg) (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ), CARBIDOPA AND LEVODOPA (500 Mg/50 Mg) (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ), SELEGILINE HCL (5 Mg) (View Selegiline Hcl Review and Selegiline Hcl Label ), CABERGOLINE (1 Mg) (View Cabergoline Review and Cabergoline Label ), PERGOLIDE (250 Ug) (View Pergolide Review and Pergolide Label ).

6648088-1 | Dysphagia, Malaise
Patient was taking Comtan (View Usage). Patient had the following side effects: dysphagia, malaise on Mar 19, 2010 from CANADA Additional patient health information: Male patient , 80 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Comtan dosage: 200 Mg, Qid. Patient was hospitalized.

6610493-7 | Chest Pain, Depersonalisation, Derealisation, Pollakiuria, Somnolence
Adverse event was reported on Feb 22, 2010 by a Male patient taking Comtan (View Usage) (Dosage: 400 Mg, Daily) was diagnosed with parkinson's disease (What is parkinson's disease?), hypoaesthesia, abdominal discomfort, depression (What is depression?) and. Location: JAPAN , weighting 138.9 lb, After Comtan was administered, patient had the following side effects: chest pain (What is chest pain?), depersonalisation, derealisation, pollakiuria, somnolence. During the same period patient was treated with CARBIDOPA AND LEVODOPA (450 Mg, Unk) (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ), PRAMIPEXOLE DIHYDROCHLORIDE (2 Mg, Unk) (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ), METHYCOBAL (1500 Ug, Unk) (View Methycobal Review and Methycobal Label ), GASTER (20 Mg, Unk) (View Gaster Review and Gaster Label ), TETRAMIDE (30 Mg, Unk) (View Tetramide Review and Tetramide Label ), RIVOTRIL (Unk) (View Rivotril Review and Rivotril Label ), SEDIEL (Unk) (View Sediel Review and Sediel Label ).

6609881-4 | Inappropriate Antidiuretic Hormone Secretion
on Feb 24, 2010 Male patient from JAPAN , 60 years of age, was treated with Comtan (View Usage). Patient experienced the following unwanted or unexpected effects: inappropriate antidiuretic hormone secretion. Comtan dosage: Unk.

6564753-9 | Finger Amputation, Fungal Infection, Malignant Melanoma, Nail Discolouration
on Jan 27, 2010 Female patient from UNITED STATES , weighting 95.98 lb, was diagnosed with parkinson's disease (What is parkinson's disease?), tremor and was treated with Comtan (View Usage). Patient had the following side effects: finger amputation, fungal infection (What is fungal infection?), malignant melanoma, nail discolouration. Comtan dosage: 200 Mg, Unk. During the same period patient was treated with SINEMET (View Sinemet Review and Sinemet Label ), MIRAPEX (View Mirapex Review and Mirapex Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ).

6505100-8 | Hyperglycaemia, International Normalised Ratio Increased
Patient was taking Comtan (View Usage). After Comtan was administered, patient had the following side effects: hyperglycaemia, international normalised ratio increased on Dec 08, 2009 from JAPAN Additional patient health information: Male patient , 72 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Comtan dosage: 300mg, Daily. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

6500489-8 | Dyskinesia, Hyperhidrosis, Vomiting
Adverse event was reported on Jan 23, 2009 by a Male patient taking Comtan (View Usage) (Dosage: 100 Mg/time) was diagnosed with dyskinesia, parkinson's disease (What is parkinson's disease?) and. Location: JAPAN , weighting 74.96 lb, Patient experienced the following unwanted or unexpected effects: dyskinesia, hyperhidrosis, vomiting. During the same period patient was treated with PARLODEL (5.0mg) (View Parlodel Review and Parlodel Label ), LEVODOPA (100 Mg) (View Levodopa Review and Levodopa Label ). Patient was hospitalized.

6479744-6 | Depersonalisation
on Nov 25, 2009 Male patient from JAPAN , 65 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Comtan (View Usage). Patient had the following side effects: depersonalisation. Comtan dosage: Unk.

6467632-0 | Finger Amputation, Fungal Infection, Malignant Melanoma, Nail Discolouration
on Nov 20, 2009 Female patient from UNITED STATES , weighting 95.98 lb, was diagnosed with parkinson's disease (What is parkinson's disease?), tremor and was treated with Comtan (View Usage). After Comtan was administered, patient had the following side effects: finger amputation, fungal infection (What is fungal infection?), malignant melanoma, nail discolouration. Comtan dosage: 3/day. During the same period patient was treated with SINEMET (View Sinemet Review and Sinemet Label ), MIRAPEX (View Mirapex Review and Mirapex Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ).

6464770-3 | Blood Creatine Phosphokinase Increased, Fall
Patient was taking Comtan (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, fall (What is fall?) on Nov 18, 2009 from JAPAN Additional patient health information: Female patient , 70 years of age, . Comtan dosage: 400 Mg. During the same period patient was treated with MENESIT (600 Mg) (View Menesit Review and Menesit Label ), SYMMETREL (200 Mg) (View Symmetrel Review and Symmetrel Label ), MUCOSTA (3 Df) (View Mucosta Review and Mucosta Label ), MUCOSOLVAN (3 Df) (View Mucosolvan Review and Mucosolvan Label ), LUDIOMIL (View Ludiomil Review and Ludiomil Label ), HALCION (View Halcion Review and Halcion Label ), RIKKUNSHI TO (View Rikkunshi-to Review and Rikkunshi-to Label ).

6455131-1 | Hallucination
Adverse event was reported on Nov 04, 2009 by a Female patient taking Comtan (View Usage) (Dosage: 300 Mg Oral) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: JAPAN , 79 years of age, Patient had the following side effects: hallucination. During the same period patient was treated with SYMMETREL (250 Mg Oral) (View Symmetrel Review and Symmetrel Label ), LEVODOPA BENSERAZIDE HYDROCHLORIDE (View Levodopa Benserazide Hydrochloride Review and Levodopa Benserazide Hydrochloride Label ), PRAMIPEXOLE DIHYDROCHLORIDE (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ), SELEGILINE HCL (View Selegiline Hcl Review and Selegiline Hcl Label ), DOPS (View Dops Review and Dops Label ), EXCEGRAN (View Excegran Review and Excegran Label ), DISOPYRAMIDE (View Disopyramide Review and Disopyramide Label ), FOSAMAX (View Fosamax Review and Fosamax Label ). Patient was hospitalized.

6438384-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Bedridden, Blood Lactate Dehydrogenase Increased, Dehydration, Eating Disorder, Hepatic Function Abnormal
on Oct 27, 2009 Male patient from JAPAN , 69 years of age, was treated with Comtan (View Usage). After Comtan was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bedridden, blood lactate dehydrogenase increased, dehydration, eating disorder (What is eating disorder?), hepatic function abnormal. Comtan dosage: 300 Mg Oral. During the same period patient was treated with LEVODOPA BENSERAZIDE HYDROCHLORIDE (View Levodopa Benserazide Hydrochloride Review and Levodopa Benserazide Hydrochloride Label ), AMANTADINE HYDROCHLORIDE (View Amantadine Hydrochloride Review and Amantadine Hydrochloride Label ), SELEGILINE HYDROCHLORIDE (View Selegiline Hydrochloride Review and Selegiline Hydrochloride Label ), DROXIDOPA (View Droxidopa Review and Droxidopa Label ). Patient was hospitalized.

6438383-3 | Blood Alkaline Phosphatase Increased, Blood Creatinine Increased, Condition Aggravated, Dyskinesia, Fatigue, Hallucination, Hypokinesia, Libido Increased, Restlessness
on Oct 24, 2009 Male patient from JAPAN , 67 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Comtan (View Usage). Patient experienced the following unwanted or unexpected effects: blood alkaline phosphatase increased, blood creatinine increased, condition aggravated, dyskinesia, fatigue, hallucination, hypokinesia, libido increased, restlessness. Comtan dosage: 400 Mg Oral; 300 Mg Oral; 200 Mg Oral;. During the same period patient was treated with CARBIDOPA AND LEVODOPA (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ), SELEGILINE HYDROCHLORIDE (View Selegiline Hydrochloride Review and Selegiline Hydrochloride Label ), PERMAX (View Permax Review and Permax Label ).

6433061-9 | Blood Alkaline Phosphatase Increased, Blood Creatine Phosphokinase Increased, Cardiac Failure, Fall, Hypoglycaemic Unconsciousness
Patient was taking Comtan (View Usage). Patient had the following side effects: blood alkaline phosphatase increased, blood creatine phosphokinase increased, cardiac failure, fall (What is fall?), hypoglycaemic unconsciousness on Oct 23, 2009 from JAPAN Additional patient health information: Male patient , 67 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Comtan dosage: 400 Mg , Oral. During the same period patient was treated with CARBIDOPA AND LEVODOPA (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ), MADOPAR (View Madopar Review and Madopar Label ), SYMMETREL (View Symmetrel Review and Symmetrel Label ), BI STEROL (View Bi-sterol Review and Bi-sterol Label ), JUVELA NICOTINATE (View Juvela Nicotinate Review and Juvela Nicotinate Label ), SELBEX (View Selbex Review and Selbex Label ). Patient was hospitalized.

6433045-0 | Erythema, Prurigo, Skin Exfoliation, Skin Lesion, Swelling
Adverse event was reported on Oct 23, 2009 by a Male patient taking Comtan (View Usage) (Dosage: 800 Mg, Oral) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: BRAZIL , 57 years of age, After Comtan was administered, patient had the following side effects: erythema, prurigo, skin exfoliation, skin lesion, swelling. During the same period patient was treated with CARBIDOPA AND LEVODOPA (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ).

6430026-8 | Device Breakage, Economic Problem, Tooth Fracture
on Nov 04, 2009 Male patient from UNITED STATES , weighting 235.0 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Comtan (View Usage). Patient experienced the following unwanted or unexpected effects: device breakage, economic problem, tooth fracture. Comtan dosage: 1 -concurrently With Carb/lev- 4 Times Daily Po.

6417316-X | Blood Glucose Increased, International Normalised Ratio Increased
on Oct 20, 2009 Male patient from JAPAN , 72 years of age, was treated with Comtan (View Usage). Patient had the following side effects: blood glucose increased, international normalised ratio increased. Comtan dosage: 300mg, Daily. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

6411698-0 | Skin Exfoliation, Skin Lesion
Patient was taking Comtan (View Usage). After Comtan was administered, patient had the following side effects: skin exfoliation, skin lesion on Oct 14, 2009 from BRAZIL Additional patient health information: Male patient , 57 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Comtan dosage: 800 Mg Daily. During the same period patient was treated with CARBIDOPA AND LEVODOPA (3 Tablets Daily) (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ).

6403773-1 | Asthenia, Decreased Appetite, Weight Decreased
Adverse event was reported on Oct 09, 2009 by a Male patient taking Comtan (View Usage) (Dosage: 800 Mg Oral) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: FRANCE , 85 years of age, Patient experienced the following unwanted or unexpected effects: asthenia, decreased appetite, weight decreased. During the same period patient was treated with EUPRESSYL (View Eupressyl Review and Eupressyl Label ), MADOPAR CR (View Madopar Cr Review and Madopar Cr Label ), RISORDAN (View Risordan Review and Risordan Label ), FELODIPINE (View Felodipine Review and Felodipine Label ).

6403771-8 | Blood Creatine Phosphokinase Increased, Fall
on Sep 28, 2009 Female patient from JAPAN , 70 years of age, was treated with Comtan (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, fall (What is fall?). Comtan dosage: 400 Mg Oral, 300 Mg Oral. During the same period patient was treated with MENESIT (View Menesit Review and Menesit Label ), SYMMETREL (View Symmetrel Review and Symmetrel Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), MUCOSOLVAN (View Mucosolvan Review and Mucosolvan Label ), LUDIOMIL (View Ludiomil Review and Ludiomil Label ), HALCION (View Halcion Review and Halcion Label ), RIKKUNSHI TO (View Rikkunshi-to Review and Rikkunshi-to Label ).

6398756-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Blood Urea Increased, Condition Aggravated, Dehydration, Eating Disorder, Hepatic Function Abnormal
on Sep 23, 2009 Male patient from JAPAN , 69 years of age, was treated with Comtan (View Usage). After Comtan was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, blood urea increased, condition aggravated, dehydration, eating disorder (What is eating disorder?), hepatic function abnormal. Comtan dosage: 300 Mg Oral. During the same period patient was treated with LEVODOPA BENSERAZIDE HYDROCHLORIDE (View Levodopa Benserazide Hydrochloride Review and Levodopa Benserazide Hydrochloride Label ), AMANTADINE HYDROCHLORIDE (View Amantadine Hydrochloride Review and Amantadine Hydrochloride Label ), SELEGILINE HYDROCHLORIDE (View Selegiline Hydrochloride Review and Selegiline Hydrochloride Label ). Patient was hospitalized.

6398755-2 | Constipation, Hallucination, Visual
Patient was taking Comtan (View Usage). Patient experienced the following unwanted or unexpected effects: constipation (What is constipation?), hallucination, visual on Sep 23, 2009 from JAPAN Additional patient health information: Female patient , 80 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Comtan dosage: 900 Mg Oral. During the same period patient was treated with LEVODOPA BENSERAZINE HYDROCHLORIDE (View Levodopa Benserazine Hydrochloride Review and Levodopa Benserazine Hydrochloride Label ), PRORENAL (View Prorenal Review and Prorenal Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), TRYPTANOL (View Tryptanol Review and Tryptanol Label ), EVISTA (View Evista Review and Evista Label ), BONALON (View Bonalon Review and Bonalon Label ), PURSENNID (View Pursennid Review and Pursennid Label ), ALOSENN (View Alosenn Review and Alosenn Label ).

6398748-5 | Haematuria
Adverse event was reported on Sep 25, 2009 by a Male patient taking Comtan (View Usage) (Dosage: 300 Mg Oral) . Location: JAPAN , 65 years of age, Patient had the following side effects: haematuria. During the same period patient was treated with CARBIDOPA AND LEVODOPA (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ), SYMMETREL (View Symmetrel Review and Symmetrel Label ), SIFROL (View Sifrol Review and Sifrol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PERSANTINE (View Persantine Review and Persantine Label ), HALCION (View Halcion Review and Halcion Label ), GASTROM (View Gastrom Review and Gastrom Label ), MICARDIS (View Micardis Review and Micardis Label ).

6383464-6 | Blood Potassium Increased, Blood Urea Increased, Eosinophilic Pneumonia, Haemoglobin Decreased, Neutrophil Count Decreased, Red Blood Cell Count Decreased
on Sep 15, 2009 Male patient from JAPAN , 83 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Comtan (View Usage). After Comtan was administered, patient had the following side effects: blood potassium increased, blood urea increased, eosinophilic pneumonia, haemoglobin decreased, neutrophil count decreased, red blood cell count decreased. Comtan dosage: 3 Df Oral. During the same period patient was treated with CABASER (View Cabaser Review and Cabaser Label ), CARBIDOPA AND LEVODOPA (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ), CHLORMADINONE ACETATE TAB (View Chlormadinone Acetate Tab Review and Chlormadinone Acetate Tab Label ), ARICEPT (View Aricept Review and Aricept Label ), TICLOPIDINE HYDROCHLORIDE (View Ticlopidine Hydrochloride Review and Ticlopidine Hydrochloride Label ), PRAMIPEXOLE DIHYDROCHLORIDE (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ), GEBEN (View Geben Review and Geben Label ), BROMELAIN (View Bromelain Review and Bromelain Label ).

6383463-4 | Depressed Mood, Hallucination, Visual, Renal Impairment
on Sep 15, 2009 Female patient from JAPAN , 85 years of age, was treated with Comtan (View Usage). Patient experienced the following unwanted or unexpected effects: depressed mood, hallucination, visual, renal impairment. Comtan dosage: 100mg/d Oral, 200 Mg Oral. During the same period patient was treated with CARBIDOPA AND LEVODOPA (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ), SYMMETREL (View Symmetrel Review and Symmetrel Label ), SELEGILINE HCL (View Selegiline Hcl Review and Selegiline Hcl Label ), PRAMIPEXOLE DIHYDROCHLORIDE (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ), DOPS (View Dops Review and Dops Label ), POLLAKISU (View Pollakisu Review and Pollakisu Label ), PLETAL (View Pletal Review and Pletal Label ).

6381689-7 | Asthenia, Decreased Appetite, Weight Decreased
Patient was taking Comtan (View Usage). Patient had the following side effects: asthenia, decreased appetite, weight decreased on Sep 17, 2009 from FRANCE Additional patient health information: Male patient , 85 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Comtan dosage: 800 Mg/day. During the same period patient was treated with MADOPAR CR (100/25 Mg) (View Madopar Cr Review and Madopar Cr Label ), RISORDAN (View Risordan Review and Risordan Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), EUPRESSYL (1 Df, Qd) (View Eupressyl Review and Eupressyl Label ).